Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
The gene p53 encodes a transcriptional activator of genes involved in growth arrest, DNA repair and apoptosis. Loss of p53 function contributes to tumour development in vivo. The transcriptional activation function of p53 is inactivated by interaction with the mdm2 gene product. Amplification of mdm2 has been observed in 36% of human sarcomas, indicating that it may represent an alternative mechanism of preventing p53 function in tumour development. To study mdm2 function in vivo, we generated an mdm2 null allele by homologous recombination. Mdm2 null mice are not viable, and further analysis revealed embryonic lethality around implantation. To examine the importance of the interaction of MDM2 with p53 in vivo, we crossed mice heterozygous for mdm2 and p53 and obtained progeny homozygous for both p53 and mdm2 null alleles. Rescue of the mdm2-/- lethality in a p53 null background suggests that a critical in vivo function of MDM2 is the negative regulation of p53 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mdm2 can recruit HDAC1 to p53 to remove these acetylation marks and allow for p53 ubiquitination and degradation [49] in in vitro and mouse models [47,50].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [50]
In the citing paper
“Loss of Mdm2 leads to cell death by apoptosis and embryonic lethality at the blastocyst stage, and this phenotype is completely rescued by concomitant deletion of p53 (Chavez-Reyes, et al., 2003; Jones, et al., 1995; Montes de Oca Luna, et al., 1995).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Montes de Oca Luna, et al., 1995
In the citing paper
“Mouse genetic models strongly suggest that MDM2 and MDMX are the two major p53 antagonists in vivo107,108”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [107]
In the citing paper
“Mouse genetic models strongly suggest that MDM2 and MDMX are the two major p53 antagonists in vivo107,108 and that they exert non-overlapping inhibitory activities towards p53 (Refs 24,109).”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [107]
In the citing paper
“The crucial importance of MDM2 in regulating p53 was demonstrated using Mdm2-null mice, which display very early embryonic lethality (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
From p53 at a glance (2010) · cites this paper as Montes de Oca Luna et al., 1995
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Research works printed but not linked: 1
- Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris C. C. Cancer Res. 54, 4855–4878 (1994).
Cited by
Items 701–800 of 1,001
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy
Yi, J., Tavana, O., Li, H., Wang, D., Baer, R. J., & Gu, W. J. (2023) · Nature Communications · doi:10.1038/s41467-023-37617-3 · Cited by 48
“More specifically, VPRBP bound a GST-fusion protein harboring the C-terminal intracellular domain (ICD, amino acids 231-290), but not theN-terminal (1-119) or middle (120-230) domains, of PD-L1 (Fig.”
BackgroundMDM2promoter SNP285 and SNP309; phylogeny and impact on cancer risk
Knappskog, S., & Lønning, P. E. (2011) · Oncotarget · doi:10.18632/oncotarget.243 · Cited by 46
“The vital importance of this MDM2 – p53 interaction is underlined by the fact that although MDM2 null mice uniformly die at an early embryonic stage, MDM2 / p53 null double knock-outs are live born with no obvious developmental defects [5, 6].”
BackgroundNovel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction
Inuzuka, H., Fukushima, H., Shaik, S., & Wei, W. (2010) · Oncotarget · doi:10.18632/oncotarget.202 · Cited by 40
“The physiological significance of this layer of regulation is demonstrated by the fact that Mdm2 knockout mice are embryonic lethal due to elevated p53 expression and this lethality can be rescued by further inactivation of p53 [17].”
BackgroundOtub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria
Chen, Y., Wang, Y.-G., Li, Y., Sun, X., & Dai, M. (2016) · Oncotarget · doi:10.18632/oncotarget.14278 · Cited by 38
“This inhibitory role is indispensable as deleting p53 rescues the lethal phenotype of the MDMX knockout mice [45–47], similar to that in MDM2−/−p53−/− double knockout mice [48, 49].”
BackgroundStructural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
Magnussen, H. M., Ahmed, S. F., Sibbet, G. J., Hristova, V. A., Nomura, K., Hock, A. K., Archibald, L. J., Jamieson, A. G., Fushman, D., Vousden, K. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15783-y · Cited by 38
MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice
Alkhalaf, M., Ganguli, G., Messaddeq, N., LeMeur, M., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202448 · Cited by 43
“Spliced RNAs are expressed at higher levels in tumours and cell lines compared to normal tissues (Sigalas et al., 1996; Montes de Oca Luna et al., 1996).”
BackgroundThe Bradykinin Type 2 Receptor Is a Target for p53-mediated Transcriptional Activation
Saifudeen, Z., Du, H., Dipp, S., & El-Dahr, S. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909810199 · Cited by 39
MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis
Mancini, F., Gentiletti, F., D'Angelo, M., Giglio, S., Nanni, S., D’Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311793200 · Cited by 45
Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress
Frenkel, J., Sherman, D., Fein, A., Schwartz, D., Almog, N., Kapon, A., Goldfinger, N., & Rotter, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202518 · Cited by 39
“The conclusion that the overexpression of wild type p53 may disrupt normal embryogenesis, is best demonstrated in studies of mdm2 knock-out mice where it was found that the lethal phenotype of mdm2 null mice can be rescued in a p53 null background (Jones et al., 1995; de Oca Luna et al., 1995).”
BackgroundFull-length hdmX transcripts decrease following genotoxic stress
Markey, M., & Berberich, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.266 · Cited by 38
“Like hdm2, the loss of hdmX is an embryonic lethal mutation that is rescued by the loss of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995; Parant et al., 2001; Marine and Jochemsen, 2005).”
MDM2 and MDMX in Cancer and Development
Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 42
Miyamoto, K., Nagai, K., Kitamura, N., Nishikawa, T., Ikegami, H., Binh, N. T., Tsukamoto, S., Matsumoto, M., Tsukiyama, T., Minami, N., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013634108 · Cited by 41
“P53 activation critically affects embryonic viability (50, 51).”
BackgroundSwitching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 49
“It is critical for p53 regulation as exemplified by the lethality of mice lacking MDM2 expression [41, 42].”
Dobbelstein, M., & Levine, A. J. (2020) · Cancer Science · doi:10.1111/cas.14433 · Cited by 37
DGKζ under stress conditions: “To be nuclear or cytoplasmic, that is the question”
Goto, K., Tanaka, T., Nakano, T., Okada, M., Hozumi, Y., Topham, M. K., & Martelli, A. M. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.08.007 · Cited by 40
ATM activity contributes to the tumor-suppressing functions of p14ARF
Li, Y., Wu, D., Chen, B., Ingram, A. J., He, L., Liu, L., Zhu, D., Kapoor, A., & Tang, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207957 · Cited by 45
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
Nieto‐Sampedro, M., Valle‐Argos, B., Gómez‐Nicola, D., Fernández‐Mayoralas, A., & Nieto‐Díaz, M. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7685 · Cited by 52
Zhang, Z., Oh, M., Sasaki, J., & Nor, J. E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03925-z · Cited by 44
Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo
Wahl, G. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401911 · Cited by 47
Lane, D. P. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh186 · Cited by 39
Lane, D. P., & Fischer, P. M. (2004) · Nature · doi:10.1038/427789a · Cited by 37
Kurokawa, K., Tanaka, T., & Kato, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202628 · Cited by 41
“The main function of MDM2 seems to negatively regulate p53 (Montes de Oca Luna et al., 1995; Jones et al., 1995; Levine, 1997), but other functions of MDM2 have been recently suggested (Piette et al., 1997).”
BackgroundGene disruption in mice: Models of development and disease
Shastry, B. S. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006865210012 · Cited by 41
Kallassy, M., Martel, N., Damour, O., Yamasaki, H., & Nakazawa, H. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199801)21:1<26::aid-mc5>3.3.co;2-p · Cited by 37
Reassessing the role of p53 in cancer and ageing from an evolutionary perspective
Aranda-Anzaldo, A., & Dent, M. A. R. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.01.001 · Cited by 36
DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction
Wang, Z. P., Inuzuka, H., Zhong, J., Fukushima, H., Wan, L., Liu, P., & Wei, W. (2012) · Oncotarget · doi:10.18632/oncotarget.640 · Cited by 44
“com/oncotarget TOPORS [8] , RFFL [9], Cop1 [10] and Pirh2 [11] have been implicated in regulating p53 stability, mouse genetic studies strongly indicate that Mdm2 (mouse double minute 2) [12, 13] is the major negative regulator for p53 stability [6].”
BackgroundNegative auto-regulators trap p53 in their web
Zhou, X., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 36
Optimal Affinity Enhancement by a Conserved Flexible Linker Controls p53 Mimicry in MdmX
Borcherds, W. M., Becker, A., Chen, L., Chen, J., Chemes, L. B., & Daughdrill, G. W. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.04.017 · Cited by 37
Liu, D.-C., Eagleman, D. E., & Tsai, N. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008364 · Cited by 37
Li, W., Peng, X., Lang, J., & Xu, C. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00631 · Cited by 39
Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching
Hilliard, S. A., Aboudehen, K., Yao, X., & El-Dahr, S. S. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.03.017 · Cited by 40
“Pursuant to the loss of Mdm2 there is an increase in the levels and/or activity of p53 compromising viability of the embryo (Chavez-Reyes et al., 2003; de Rozieres et al., 2000; Montes de Oca Luna et al., 1995).”
InfluentialInduction of Cullin 7 by DNA damage attenuates p53 function
Jung, P., Verdoodt, B., Bailey, A. O., Yates, J. R., Menssen, A., & Hermeking, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609467104 · Cited by 41
Effects of in vitro fertilization and embryo culture on TRP53 and Bax expression in B6 mouse embryos
Chandrakanthan, V., Li, A., Chami, O., & O’Neill, C. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-61 · Cited by 36
Yang, H. L., Dong, Y., Elliott, M. J., Liu, T. J., Atienza, C. A., Stilwell, A., & McMasters, K. M. (1999) · PubMed · Cited by 36
Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation In Vivo
De Clercq, S., Gembarska, A., Denecker, G., Maetens, M., Naessens, M., Haigh, K., Haigh, J. J., & Marine, J.-C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00330-10 · Cited by 35
“null, Mdm4-null, and E -myc alleles was done as previously described (1, 7, 14, 32, 35).”
MethodBattle Against Cancer: An Everlasting Saga of p53
Hao, Q., & Cho, W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151222109 · Cited by 48
Johnson, T. M., Meade, K., Pathak, N., Marques, M. R., & Attardi, L. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706764105 · Cited by 35
Steinman, H. A., Sluss, H. K., Sands, A., Pihan, G. A., & Jones, S. N. (2004) · Oncogene · doi:10.1038/sj.onc.1206925 · Cited by 40
“Although the early embryonic lethality of Mdm2-null mice makes it difficult to determine which p53 functions are being downregulated by Mdm2 during development, the absence of p21 does not rescue Mdm2-null mice, suggesting that Mdm2 may be specifically downregulating the apoptotic functions of p53 (Montes de Oca Luna…”
BackgroundCytoplasmic localization of DGKζ exerts a protective effect against p53-mediated cytotoxicity
Tanaka, T., Okada, M., Hozumi, Y., Tachibana, K., Kitanaka, C., Hamamoto, Y., Martelli, A. M., Topham, M. K., Iino, M., & Goto, K. (2013) · Journal of Cell Science · doi:10.1242/jcs.118711 · Cited by 43
“DGKf-deficient mice develop normally with no obvious phenotype under physiological conditions, which contrasts sharply against Mdm2-deficient mice, which are embryonic lethal because of excessive apoptosis induced by increased levels of p53 protein and its activity (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundFunctions of p53 in metabolism and invasion
Vousden, K. H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370511 · Cited by 42
Hsing, A. Y., Faller, D. V., & Vaziri, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002455200 · Cited by 35
Jiang, Y., Yang, W., Zhou, Y., & Ma, L. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.053 · Cited by 35
Trinh, E., Boutillier, A., & Loeffler, J. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0928 · Cited by 35
Latonen, L., Kurki, S., Pitkänen, K., & Laiho, M. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00044-x · Cited by 39
Węsierska‐Gądek, J., Wojciechowski, J., & Schmid, G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10521 · Cited by 44
The contribution of the RING finger domain of MDM2 to cell cycle progression
Argentini, M., Barboule, N., & Wasylyk, B. (2000) · Oncogene · doi:10.1038/sj.onc.1203737 · Cited by 39
“MDM2 down-regulation of p53 is critically important, as shown in mice by the rescue of the early embryonic lethality resulting from inactivation of the Mdm2 gene by inactivation of the p53 gene (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundMdmX regulates transformation and chromosomal stability in p53-deficient cells
Matijasevic, Z., Krzywicka-Racka, A., Sluder, G., & Jones, S. N. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6797 · Cited by 34
Borthakur, G. M., Duvvuri, S. R., Ruvolo, V. R., Tripathi, D. N., Piya, S., Burks, J. K., Jacamo, R. O., Kojima, K., Ruvolo, P. P., Fueyo-Margareto, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139254 · Cited by 37
“MDM2 (HDM2 in humans), a E3 ubiquitin ligase, is a key regulator of p53 function through its role in proteasomal degradation of p53.[1, 2] Small molecule inhibitors of MDM2 that can restore wild type p53 activity in a non-genotoxic manner and thereby activate apoptotic cell death, are in clinical development as treatm…”
BackgroundCarr, M. I., Roderick, J. E., Gannon, H., Kelliher, M. A., & Jones, S. N. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.014 · Cited by 35
SMG7 is a critical regulator of p53 stability and function in DNA damage stress response
Luo, H., Cowen, L. E., Yu, G., Jiang, W. G., & Tang, Y. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.42 · Cited by 41
Jean‐Charles, P., Yu, S. M.-W., Abraham, D., Kommaddi, R. P., Mao, L., Strachan, R. T., Zhang, Z.-S., Bowles, D. E., Brian, L., Stiber, J. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95998 · Cited by 36
Genetic alterations in pancreatic cancer
Saif, M. W., Karapanagiotou, L., & Syrigos, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i33.4423 · Cited by 40
“It was suggested that expression of mdm-2 gene is regulated by p53 tumor suppressor gene but Ruggeri et al proved that there is no association between these two genes and moreover amplification and overexpression of mdm-2 is an infrequent event in the development of pancreatic adenocarcinomas [ 47 ]”
BackgroundMDM2 as MYCN transcriptional target: Implications for neuroblastoma pathogenesis
Slack, A., Lozano, G., & Shohet, J. M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.050 · Cited by 39
Self-citationWęsierska‐Gądek, J., & Schmid, G. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.1.23 · Cited by 37
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
Jackson, M. W., Agarwal, M. K., Agarwal, M. L., Agarwal, A. M., Stanhope-Baker, P., Williams, B. R. G., & Stark, G. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207575 · Cited by 37
“The importance of MDM2 is demonstrated by the phenotype of mdm2-null mice, which die early in embryogenesis due to deregulated p53 expression (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundLi, Y., Chandrakanthan, V., Day, M. L., & O’Neill, C. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.060129 · Cited by 36
Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
Meng, R. D., Shih, H. A., Prabhu, N. S., George, D. L., & El‐Deiry, W. S. (1998) · PubMed · Cited by 36
The roles of MDM2 and MDMX phosphorylation in stress signaling to p53
Chen, J. (2012) · Genes & Cancer · doi:10.1177/1947601912454733 · Cited by 33
Fouchécourt, S., Livera, G., Messiaen, S., Fumel, B., Parent, A.-S., Marine, J., & Monget, P. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.120 · Cited by 33
The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination
Cubillos‐Rojas, M., Schneider, T., Hadjebi, O., Pedrazza, L., de Oliveira, J. R., Vives, F. L., Guénet, J., Duran, J., de Anta, J. M., Alcántara, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11270 · Cited by 37
“The lethality during these phases was rescued by a double knockout of the ubiquitin ligase and p53 [33-35].”
BackgroundGerm cell determination and the developmental origin of germ cell tumors
Nicholls, P. K., & Page, D. C. (2021) · Development · doi:10.1242/dev.198150 · Cited by 34
The p53 Family: A Role in Lipid and Iron Metabolism
Laubach, K., Zhang, J., & Chen, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715974 · Cited by 37
“Later, it was discovered that p53 dysregulation, predominantly overexpression, can lead to impaired embryogenesis and other developmental defects (Luna et al., 1995; Sah et al., 1995; Parant et al., 2001; Zhang et al., 2012; Nostrand et al., 2014).”
BackgroundMDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity
Chinnam, M., Xu, C., Lama, R., Zhang, X., Cedeno, C. D., Wang, Y., Stablewski, A. B., Goodrich, D. W., & Wang, X. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010171 · Cited by 53
“p53/Mdm2 double knockout MEFs [30] and p53/Mdm2/Mdm4 triple knockout (TriKO) MEFs [24] (gifts from Gigi Lozano, MD Anderson Cancer Center, Houston, TX) and p53-null prostate cancer cell line PC3 (ATCC) were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal calf serum (FCS, Atlanta Bio…”
MethodDolezelova, P., Cetkovska, K., Vousden, K. H., & Uldrijan, S. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19445 · Cited by 32
“Targeted deletion of genes coding for Mdm2 or MdmX in mice leads to embryonic lethality, which can be rescued by concomitant deletion of the p53 gene, indicating a critical role for both Mdm2 and MdmX in controlling p53 activity during embryonic development.(9,10) Interestingly, while the expression of the p53 inhibit…”
BackgroundGenetic control of susceptibility to spontaneous testicular germ cell tumors in mice
Lam, M.-Y., & Nadeau, J. H. (2003) · Apmis · doi:10.1034/j.1600-0463.2003.11101221.x · Cited by 33
“In many other systems, double-mutant mice show suppressed phenotypes, because one mutant suppresses the phenotype of the other, or novel phenotypes are found (38, 39).”
BackgroundEischen, C. M., Alt, J. R., & Wang, P. (2004) · Oncogene · doi:10.1038/sj.onc.1208052 · Cited by 34
“TheMdm2þ / (C57Bl/6 129/Sv) (Montes de Oca Luna et al., 1995) and the ARF / (congenic C57Bl/6) mice (Kamijo et al., 1997) were kindly provided by Dr Guillermina Lozano (MD Anderson Cancer Center, Houston, TX, USA) and Drs Charles Sherr and Martine Roussel (St Jude Children’s Research Hospital,…”
BackgroundMethodSubstrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization
Sun, L., Shi, L., Wang, F., Huangyang, P., Si, W., Yang, J., Yao, Z., & Shang, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195115 · Cited by 33
Qiu, S., Ye, S.-L., Wu, Z.-Q., Tang, Z., & Liu, Y.-K. (1998) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050162 · Cited by 35
Exploiting the p53 pathway for cancer diagnosis and therapy.
Lane, D. P. (1999) · PubMed · Cited by 46
Abnormal MDMX degradation in tumor cells due to ARF deficiency
Li, X., Gilkes, D., Li, B., Cheng, Q., Pernazza, D., Lawrence, H., Lawrence, N., & Chen, J. (2012) · Oncogene · doi:10.1038/onc.2011.534 · Cited by 32
“Mouse models showed that the expression and E3 ligase activity of MDM2 are critical for preventing p53 hyper activation and ensuring the survival of mouse embryos (Itahana et al 2007, Jones et al 1995, Montes de Oca Luna et al 1995).”
Vlangos, C. N., O'Connor, B. C., Morley, M. J., Krause, A. S., Osawa, G. A., & Keegan, C. E. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.07.038 · Cited by 29
“…with genomic instability, p53 deficiency rescues embryonic lethality caused by disruption of the DNA repair genes Xrcc4 and DNA ligase IV and the p53-interacting proteins Mdm2 and Mdm4 (Frank et al., 2000; Gao et al., 2000; Jones et al., 1995; Montes de Oca Luna et al., 1995; Parant et al., 2001).”
BackgroundInhibitors of MDM2 and MDMX: A Structural Perspective
Riedinger, C., & McDonnell, J. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.75 · Cited by 37
UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
Du, C., Wu, H., & Leng, R. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6555 · Cited by 32
Liu, H., Chen, F., Zhang, L., Zhou, Q., Gui, S., & WANG, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.4795 · Cited by 32
Duan, Y., Ma, G., Huang, X., D'Amore, P. A., Zhang, F., & Lei, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729467 · Cited by 34
“The phenotype of murine embryonic lethality of MDM2 null can be prevented by knocking out the p53 gene (12, 13).”
The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis
Xiong, S., Pant, V., Zhang, Y., Aryal, N. K., You, M. J., Kusewitt, D. F., & Lozano, G. (2016) · The Journal of Pathology · doi:10.1002/path.4854 · Cited by 33
Self-citationKinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2
Yadahalli, S., Neira, J. L., Johnson, C. M., Tan, Y. S., Rowling, P. J. E., Chattopadhyay, A., Verma, C. S., & Itzhaki, L. S. (2019) · Scientific Reports · doi:10.1038/s41598-018-36589-5 · Cited by 34
Trp53 regulates Notch 4 signaling through Mdm2
Sun, Y., Klauzińska, M., Lake, R. J., Lee, J. M., Santopietro, S., Raafat, A. M., Salomon, D. S., Callahan, R., & Artavanis‐Tsakonas, S. (2011) · Journal of Cell Science · doi:10.1242/jcs.068965 · Cited by 35
“…cultured with RPMI-1640 medium, supplemented with 10% FBS. HeLa cells were grown in DMEM, supplemented with 10% FBS. Wild-type, Trp53-null and Mdm2-null MEFs (Montes de Oca Luna et al., 1995) were kindly provided by Guillermina Lozano (University of Texas M.D. Anderson Cancer Center, Houston, TX).”
MethodInfluentialStochastic Modeling and Simulation of the p53-MDM2/MDMX Loop
Cai, X., & Yuan, Z.-M. (2009) · Journal of Computational Biology · doi:10.1089/cmb.2008.0231 · Cited by 33
“MDM2-null mouse embryos die very early in development due to increased apoptosis (Jones et al., 1995; Montes de Oca Luna et al., 1995), whereas MDMX-null mouse embryos die later probably because of cell proliferation arrest (Parant et al., 2001; Finch et al., 2002; Migliorini et al., 2002).”
Kulkarni, D. A., Vázquez, A., Haffty, B. G., Bandera, E. V., Hu, W., Sun, Y., Toppmeyer, D., Levine, A. J., & Hirshfield, K. M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp224 · Cited by 36
Artemis is a negative regulator of p53 in response to oxidative stress
Zhang, X., Zhu, Y., Geng, L., Wang, H., & Legerski, R. J. (2009) · Oncogene · doi:10.1038/onc.2009.100 · Cited by 34
“High levels of p53 are known to result in an embryonic lethal phenotype such as is observed in Mdm2 nullizygous mice (Montes de Oca Luna et al. , 1995).”
Dimerization of CUL7 and PARC Is Not Required for All CUL7 Functions and Mouse Development
Skaar, J. R., Arai, T., & DeCaprio, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5579-5589.2005 · Cited by 32
“If PARC functioned as an inhibitor of p53 activity, the Parc knockout mouse should exhibit a phenotype similar to that of the Mdm2 knockout, which exhibits early embryonic lethality due to the inability to deactivate p53 (12, 19).”
BackgroundTumor Suppressor Genes and Human Cancer
Brown, M. A. (1997) · Advances in genetics · doi:10.1016/s0065-2660(08)60307-7 · Cited by 39
Katz, C., Low-Calle, A. M., Choe, J. H., Laptenko, O., Tong, D., Joseph-Chowdhury, J.-S. N., Garofalo, F., Zhu, Y. Y., Friedler, A., & Prives, C. L. (2018) · Genes & Development · doi:10.1101/gad.304071.117 · Cited by 34
“The crucial role of MDM2 as the obligate negative regulator needed to keep p53 in check has been well validated by extensive mouse models (Jones et al. 1995; Montes de Oca Luna et al. 1995; Xiong 2013).”
The ups and downs of p53 regulation in hematopoietic stem cells
Abbas, H. A., Pant, V., & Lozano, G. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17721 · Cited by 33
“Mdm2 and Mdm4 play major roles in this regulation as genetic ablation of either gene in mice results in embryonic lethal phenotypes that are rescued by deletion of both p53 alleles.(2-4) The ups and downs of p53 regulation in hematopoietic stem cells”
BackgroundSelf-citationNutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30
Rizzotto, D., Zaccara, S., Rossi, A., Galbraith, M. D., Andrysík, Z., Pandey, A., Sullivan, K. D., Quattrone, A., Espinosa, J. M., Dassi, E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.011 · Cited by 31
Naderi, E. H., Jochemsen, A. G., Blomhoff, H. K., & Naderi, S. (2011) · Neoplasia · doi:10.1593/neo.11542 · Cited by 35
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Timofeev, O. N., Klimovich, B., Schneikert, J., Wanzel, M., Pavlakis, E., Noll, J., Mutlu, S., Elmshäuser, S., Nist, A., Mernberger, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019102096 · Cited by 33
“5, whereas simultaneous disruption of the Trp53 gene rescues the lethal phenotype (Jones et al , 1995; Montes de Oca Luna et al , 1995; Chavez-Reyes et al , 2003).”
Mtbp haploinsufficiency in mice increases tumor metastasis
Iwakuma, T., Tochigi, Y., Pelt, C. S. V., Caldwell, L. C., Terzian, T., Parant, J. M., Chau, G. P., Koch, J. G., Eischen, C. M., & Lozano, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210827 · Cited by 31
“Mdm2-null mice show embryonic lethality that is completely rescued by a concomitant deletion of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
BackgroundSelf-citationRoth, J., Dobbelstein, M., Freedman, D., Shenk, T. E., & Levine, A. J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)82742-x · Cited by 32
Evidence that the Human Cytomegalovirus IE2-86 Protein Binds mdm2 and Facilitates mdm2 Degradation
Zhang, Z., Evers, D. L., McCarville, J. F., Dantonel, J.-C., Huong, S., & Huang, E. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.3833-3843.2006 · Cited by 31
“Mdm2 knockouts are embryonic lethal and can be rescued by codeletion of p53 (36, 50).”
BackgroundNeel, H., Daujat, S., Piette, J., Thisse, C., & Thisse, B. (2000) · Differentiation · doi:10.1046/j.1432-0436.2000.660201.x · Cited by 36
Increased Mdm2 Expression in Rat Brain after Transient Middle Cerebral Artery Occlusion
Tu, Y., Hou, S., Huang, Z., Robertson, G. S., & MacManus, J. P. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199806000-00008 · Cited by 33
Dong, P., Ihira, K., Hamada, J., Watari, H., Yamada, T., Hosaka, M., Hanley, S. J. B., 工藤, 正., & Sakuragi, N. (2015) · Oncotarget · doi:10.18632/oncotarget.4847 · Cited by 34
“MDM2 limits p53 activity by binding to and blocking the N-terminal trans-activation domain of p53, or by working as an E3 ubiquitin ligase to promote p53 degradation [32, 33].”
The role of mRNA decay in p53-induced gene expression
Melanson, B. D., Bose, R., Hamill, J. D., Marcellus, K. A., Pan, E., & McKay, B. C. (2011) · RNA · doi:10.1261/rna.030122.111 · Cited by 38
“First, the rapid turnover of p53-responsive transcripts protects cells from the spurious p53 activation because sustained activation of p53 is incompatible with life (Jones et al. 1995; Montes de Oca Luna et al. 1995).”
BackgroundMdm2 enhances ligase activity of parkin and facilitates mitophagy
Kook, S., Zhan, X., Thibeault, K. C., Ahmed, M. R., Gurevich, V. V., & Gurevich, E. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-61796-4 · Cited by 34
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
Giansanti, C., Manzini, V., Dickmanns, A., Dickmanns, A., Palumbieri, M. D., Sanchi, A., Kienle, S. M., Rieth, S., Scheffner, M., Lopes, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110879 · Cited by 37
Andrysík, Z., Sullivan, K. D., Kieft, J. S., & Espinosa, J. M. (2022) · Nature Communications · doi:10.1038/s41467-022-35089-5 · Cited by 33
Dissecting the p53-Mdm2 feedback loop in vivo : uncoupling the role in p53 stability and activity
Pant, V., & Lozano, G. (2014) · Oncotarget · doi:10.18632/oncotarget.1797 · Cited by 30
“In contrast, previous studies have shown that mice which completely lack Mdm2 are embryo lethal and die due to increased p53 activity [3, 4].”
BackgroundResultSelf-citationp53: a molecular marker for the detection of cancer
Boyd, M. T., & Vlatković, N. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.9.1013 · Cited by 33
“(2008) 2(9) rescued by concomitant deletion of p53 demonstrates that the lethality observed is due to p53 [56-58] .”
Metadata
- Authors
- de Oca Luna, R. M., Wagner, D. S., & Lozano, G.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Nature
- Published
- 1995-11
- Volume
- 378
- Issue
- 6553
- Pages
- 203-206
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969044026
- Semantic Scholar
- e682601f6b2b8de8fa63cc39518a1461943483bc
- Cited by
- 1,420
- References
- 29
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 31 · 2023: 30 · 2022: 31 · 2021: 32 · 2020: 49 · 2019: 29 · 2018: 32 · 2017: 49 · 2016: 63 · 2015: 44 · 2014: 67 · 2013: 37 · 2012: 63
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, embryonic lethality, p53-MDM2 interaction, tumor suppressor, sarcoma, homologous recombination, DNA repair
- MeSH terms
- Animals, Base Sequence, Cell Line, Crosses, Genetic, Female, Genes, Lethal, Heterozygote, Homozygote, Male, Mice, Inbred C57BL, Molecular Sequence Data, Nuclear Proteins, Proto-Oncogene Proteins, Tumor Suppressor Protein p53, Gene Deletion, DNA Primers, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.